← Back to Search

Exercise for Cognitive Impairment in Breast Cancer Survivors (ICAN Trial)

N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 6 months and baseline to 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will see if an exercise intervention can improve thinking skills in breast cancer survivors and help create exercise guidelines for them.

Who is the study for?
This trial is for breast cancer survivors who finished treatment at least 6 months ago but within the last 5 years, have low physical activity levels, own a Fitbit-compatible device with internet, and experience cognitive difficulties post-diagnosis. It's not for those with medical conditions that make unsupervised exercise unsafe or those unable to commit to a year-long study.
What is being tested?
The study is examining if an exercise program can boost brain function in breast cancer survivors. Participants will either engage in this physical activity intervention or be part of a control group without the special exercise regimen.
What are the potential side effects?
Since the intervention involves physical activity, potential side effects may include typical exercise-related issues such as muscle soreness, fatigue, or injury. However, these are generally mild and manageable.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 6 months and baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months and baseline to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
National Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digital Test
Patient Reported Outcomes Measurement Information System (PROMIS) cognitive abilities

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise InterventionExperimental Treatment1 Intervention
This arm will receive a 12-month individually tailored phone and email-based exercise program.
Group II: Health & Wellness InterventionActive Control1 Intervention
This arm will receive a 12-month health and wellness program.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~820

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,189 Previous Clinical Trials
1,587,488 Total Patients Enrolled
6 Trials studying Dementia
1,719 Patients Enrolled for Dementia

Media Library

Exercise Clinical Trial Eligibility Overview. Trial Name: NCT04049695 — N/A
Dementia Research Study Groups: Exercise Intervention, Health & Wellness Intervention
Dementia Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT04049695 — N/A
Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT04049695 — N/A
~40 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top